Discover Tenders by Unwrought Semi Precious Products Sector

Find the most relevant tenders for Unwrought Semi Precious Products. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Unwrought Semi Precious Products tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Unwrought Semi Precious Products tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Medicines With The Active Ingredient Rivaroxaban Atc B01Af01 In All Potencies Except 2 5 Mg Per Divided Oral Dosage Form

Deadline: 30 Apr 2026

Germany

Ref. No.: 5771252

EMD:Ref Document

Bid Value: Ref Document

182 Days Left

Medicines With The Active Ingredient Rivaroxaban Atc B01Af01 With A Potency Of 2 5 Mg Per Divided Oral Dosage Form

Deadline: 30 Apr 2026

Germany

Ref. No.: 5769473

EMD:Ref Document

Bid Value: Ref Document

182 Days Left

Medicines With The Active Ingredient Testosterone Atc G03Ba03 In The Dosage Form Injection Solution

Deadline: 30 Apr 2026

Germany

Ref. No.: 5762364

EMD:Ref Document

Bid Value: Ref Document

182 Days Left

Nga Boosting Innovative Geoint Science Technology Broad Agency Announcement Big St Baa

Deadline: 14 Dec 2026

United States

Ref. No.: 5760635

EMD:Ref Document

Bid Value: Ref Document

410 Days Left

Dps For Skills And Investment Grant Funding

Deadline: 30 Sep 2028

Great Britain

Ref. No.: 5750837

EMD:Ref Document

Bid Value: Ref Document

1066 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Lipegfilgrastim L03Aa14 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5729395

EMD:Ref Document

Bid Value: Ref Document

182 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5728730

EMD:Ref Document

Bid Value: Ref Document

192 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ganirelix H01Cc01 Within The Framework Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5727688

EMD:Ref Document

Bid Value: Ref Document

182 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredients Bismuth Subcitrate Tetracycline And Metronidazole A02Bd08 As Part Of A So Called Open Hou

Deadline: 30 Apr 2026

Germany

Ref. No.: 5723430

EMD:Ref Document

Bid Value: Ref Document

182 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab

Deadline: 11 May 2026

Germany

Ref. No.: 5718497

EMD:Ref Document

Bid Value: Ref Document

193 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Budesonide Atc Code According To Who A07Ea06

Deadline: 30 Apr 2026

Germany

Ref. No.: 5718312

EMD:Ref Document

Bid Value: Ref Document

182 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Para 8 Sgb V For The Active Ingredient Rituximab

Deadline: 11 May 2026

Germany

Ref. No.: 5716614

EMD:Ref Document

Bid Value: Ref Document

193 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Follitropin Alfa G03Ga05 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5715804

EMD:Ref Document

Bid Value: Ref Document

182 Days Left

Devcom Army Research Laboratory Broad Agency Announcement For Foundational Research

Deadline: 20 Nov 2027

United States

Ref. No.: 5709177

EMD:Ref Document

Bid Value: Ref Document

751 Days Left

Open House Drug Discount Agreements Abatacept Atc Code L04Aa24

Deadline: 05 May 2026

Germany

Ref. No.: 5701703

EMD:Ref Document

Bid Value: Ref Document

187 Days Left

Showing 52216 to 52230 of 52681 results

‹
1
2
...
3479
3480
3481
3482
3483
3484
3485
...
3512
3513
›

Discover Tenders by Unwrought Semi Precious Products Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Unwrought Semi Precious Products Sector

Filter Your Search

FREE Trial plan for all new users!